Seattle, WA, United States of America

Jeffrey Whiteaker

This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignees: Fred Hutchinson Cancer Center, Seattle Children's Hospital. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jeffrey Whiteaker. Retrieved from https://idiyas.com/inventor/jeffrey-whiteaker

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Jeffrey Whiteaker

Introduction

Jeffrey Whiteaker is a notable inventor based in Seattle, WA. He has made significant contributions to the field of medical diagnostics, particularly in newborn screening. His work focuses on early detection of critical disorders that can have life-threatening consequences if not identified promptly.

Latest Patents

One of Jeffrey Whiteaker's key patents is titled "Newborn screening for primary immunodeficiencies, cystinosis, and Wilson disease." This innovative screening method utilizes dried blood spots collected at birth to detect these serious conditions. Early identification of these disorders is crucial, as it can greatly improve patient outcomes and potentially save lives.

Career Highlights

Throughout his career, Jeffrey has worked with esteemed institutions such as Seattle Children's Hospital and Fred Hutchinson Cancer Research Center. His experience in these organizations has allowed him to contribute to groundbreaking research and advancements in pediatric healthcare.

Collaborations

Jeffrey has collaborated with talented individuals in his field, including Sihoun Hahn and Sunhee Jung. Their combined expertise has furthered the development of effective screening methods and improved healthcare solutions.

Conclusion

Jeffrey Whiteaker's contributions to newborn screening represent a significant advancement in medical diagnostics. His innovative approach has the potential to save lives through early detection of critical disorders.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…